The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
MicroRNA-145 Targeted Therapy Reduces Atherosclerosis
Open accessAbstract
Background—: MicroRNA are essential posttranscriptional modulators of gene expression implicated in various chronic diseases. Because microRNA-145 is highly expressed in vascular smooth muscle cells (VSMC) and regulates VSMC fate and plasticity, we hypothesized that it may be a novel regulator of atherosclerosis and plaque stability. Methods and Results—: Apolipoprotein E knockout mice ( ApoE −/− ) mice were treated with either a microRNA-145 lentivirus under the control of the smooth muscle cell (SMC)-specific promoter SM22 α or a SM22 α control lentivirus before commencing the Western diet for 12 weeks. The SMC-targeted microRNA-145 treatment markedly reduced plaque size in aortic sinuses, ascending aortas, and brachiocephalic arteries. It also significantly increased fibrous cap area, reduced necrotic core area, and increased plaque collagen content. Cellular plaque composition analyses revealed significantly less macrophages in ApoE −/− mice treated with the SMC-specific microRNA-145. These mice also demonstrated marked increases in calponin levels and α-smooth muscle actin–positive SMC areas in their atherosclerotic lesions. Furthermore, lentiviral delivery of microRNA-145 resulted in reduced KLF4 and elevated myocardin expression in aortas from ApoE −/− mice, consistent with an effect of microRNA-145 to promote a contractile phenotype in VSMC. Conclusions—: VSMC-specific overexpression of microRNA-145 is a novel in vivo therapeutic target to limit atherosclerotic plaque morphology and cellular composition, shifting the balance toward plaque stability vs plaque rupture.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Most mammalian mRNAs are conserved targets of microRNAs
Friedman, R. C., Farh, K. K.-H., Burge, C. B., & Bartel, D. P. (2009) · Genome Research · doi:10.1101/gr.082701.108 · Cited by 8,462
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
The Diverse Functions of MicroRNAs in Animal Development and Disease
Kloosterman, W. P., & Plasterk, R. H. A. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.09.009 · Cited by 2,082
miR-145 and miR-143 regulate smooth muscle cell fate and plasticity
Cordes, K. R., Sheehy, N. T., White, M. P., Berry, E. C., Morton, S. U., Muth, A. N., Lee, T.-H., Miano, J. M., Ivey, K. N., & Srivastava, D. (2009) · Nature · doi:10.1038/nature08195 · Cited by 1,585
Argonaute2, a Link Between Genetic and Biochemical Analyses of RNAi
Hammond, S. M., Boettcher, S., Caudy, A. A., Kobayashi, R., & Hannon, G. J. (2001) · Science · doi:10.1126/science.1064023 · Cited by 1,580
Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs
Hergenreider, E., Heydt, S., Tréguer, K., Boettger, T., Horrevoets, A. J. G., Zeiher, A. M., Scheffer, M. P., Frangakis, A. S., Yin, X., Mayr, M., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2441 · Cited by 1,305
Inflammation and cardiovascular disease mechanisms
Libby, P. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.456s · Cited by 1,104
Ji, R., Cheng, Y., Yue, J., Yang, J., Liu, X., Chen, H., Dean, D. B., & Zhang, C. (2007) · Circulation Research · doi:10.1161/circresaha.106.141986 · Cited by 920
An Analysis of Human MicroRNA and Disease Associations
Lu, M., Zhang, Q., Deng, M., Miao, J., Guo, Y., Gao, W., & Cui, Q. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003420 · Cited by 902
Role of Smooth Muscle Cells in the Initiation and Early Progression of Atherosclerosis
Doran, A. C., Meller, N., & McNamara, C. A. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.159327 · Cited by 804
Cheng, Y., Liu, X., Yang, J., Lin, Y., Xu, D.-Z., Lu, Q., Deitch, E. A., Huo, Y., Delphin, E. S., & Zhang, C. (2009) · Circulation Research · doi:10.1161/circresaha.109.197517 · Cited by 657
Boettger, T., Beetz, N., Kostin, S., Schneider, J., Krüger, M., Hein, L., & Braun, T. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38864 · Cited by 651
Clarke, M. C. H., Figg, N., Maguire, J. J., Davenport, A. P., Goddard, M., Littlewood, T. D., & Bennett, M. R. (2006) · Nature Medicine · doi:10.1038/nm1459 · Cited by 646
A developmental view of microRNA function
ZHAO, Y., & SRIVASTAVA, D. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.02.006 · Cited by 584
Elia, L., Quintavalle, M., Zhang, J., Contu, R., Cossu, L., Latronico, M. V. G., Peterson, K. L., Indolfi, C., Catalucci, D., Chen, J., et al. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.153 · Cited by 560
Li, L., Miano, J. M., Mercer, B., & Olson, E. N. (1996) · The Journal of cell biology · doi:10.1083/jcb.132.5.849 · Cited by 321
Loss of Akt1 Leads to Severe Atherosclerosis and Occlusive Coronary Artery Disease
Fernández-Hernando, C., Ackah, E., Yu, J., Suárez, Y., Murata, T., Iwakiri, Y., Prendergast, J., Miao, R. Q., Birnbaum, M. J., & Sessa, W. C. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.007 · Cited by 284
Complex Regulation and Function of the Inflammatory Smooth Muscle Cell Phenotype in Atherosclerosis
Orr, A. W., Hastings, N. E., Blackman, B. R., & Wamhoff, B. R. (2010) · Journal of Vascular Research · doi:10.1159/000250095 · Cited by 275
MicroRNAs Are Necessary for Vascular Smooth Muscle Growth, Differentiation, and Function
Albinsson, S., Suarez, Y., Skoura, A., Offermanns, S., Miano, J. M., & Sessa, W. C. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.200873 · Cited by 253
miR-143 and miR-145: Molecular Keys to Switch the Phenotype of Vascular Smooth Muscle Cells
Rangrez, A. Y., Massy, Z. A., Metzinger-Le Meuth, V., & Metzinger, L. (2011) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.110.958702 · Cited by 210
Jørgensen, S., Baker, A., Møller, S., & Nielsen, B. S. (2010) · Methods · doi:10.1016/j.ymeth.2010.07.002 · Cited by 189
Moessler, H., Mericskay, M., Li, Z., Nagl, S., Paulin, D., & Small, J. V. (1996) · Development · doi:10.1242/dev.122.8.2415 · Cited by 153
Rethinking Primary Prevention of Atherosclerosis-Related Diseases
Claudio Napoli, A., Lerman, L. O., de Nigris, F., Gössl, M., Balestrieri, M. L., & Lerman, A. (2006) · Circulation · doi:10.1161/circulationaha.105.570358 · Cited by 106
MicroRNA-145 in vascular smooth muscle cell biology: A new therapeutic target for vascular disease
Zhang, C. (2009) · Cell Cycle · doi:10.4161/cc.8.21.9837 · Cited by 96
Yoshioka, T., Okada, T., Maeda, Y., Ikeda, U., Shimpo, M., Nomoto, T., Takeuchi, K., Nonaka‐Sarukawa, M., Ito, T., Takahashi, M., et al. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302348 · Cited by 79
Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer
Kang, Y., Xie, L., Tran, D. T., Stein, C. S., Hickey, M. A., Davidson, B. L., & McCray, P. B. (2005) · Blood · doi:10.1182/blood-2004-11-4358 · Cited by 78
Can microRNAs control vascular smooth muscle phenotypic modulation and the response to injury?
Albinsson, S., & Sessa, W. C. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00146.2010 · Cited by 78
Shai, S., Sukhanov, S., Higashi, Y., Vaughn, C., KELLY, J. A., & Delafontaine, P. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.210831 · Cited by 72
Microribonucleic Acids for Prevention of Plaque Rupture and In-Stent Restenosis
O’Sullivan, J., Martin, K., & Caplice, N. M. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.029 · Cited by 35
Enhanced Gene Expression Conferred by Stepwise Modification of a Nonprimate Lentiviral Vector
Sinn, P. L., Goreham-Voss, J. D., Arias, A. C., Hickey, M. A., Maury, W. J., Chikkanna-Gowda, C. P., & McCray, P. B. (2007) · Human Gene Therapy · doi:10.1089/hum.2006.127 · Cited by 30
Cited by
MicroRNA Regulation of Atherosclerosis
Feinberg, M. W., & Moore, K. J. (2016) · Circulation Research · doi:10.1161/circresaha.115.306300 · Cited by 627
Vascular endothelium – Gatekeeper of vessel health
Cahill, P. A., & Redmond, E. M. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.03.007 · Cited by 518
MicroRNAs in cardiovascular disease: an introduction for clinicians
Romaine, S. P. R., Tomaszewski, M., Condorelli, G., & Samani, N. J. (2015) · Heart · doi:10.1136/heartjnl-2013-305402 · Cited by 476
MicroRNAs in Cardiovascular Disease
Barwari, T., Joshi, A., & Mayr, M. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.945 · Cited by 445
Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives
Poller, W., Dimmeler, S., Heymans, S., Zeller, T., Haas, J., Karakas, M., Leistner, D.-M., Jakob, P., Nakagawa, S., Blankenberg, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx165 · Cited by 408
Metadata
- Authors
- Lovren, F., Pan, Y., Quan, A., Singh, K. K., Shukla, P. C., Gupta, N., Steer, B. M., Ingram, A. J., Gupta, M., Al-Omran, M., Teoh, H., Marsden, P. A., & Verma, S.
- Venue
- Circulation
- Published
- 2012-09-11
- Volume
- 126
- Issue
- 11_suppl_1
- Pages
- S81-90
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2094644076
- Cited by
- 281
- References
- 34
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.